Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Endo Health Solutions Inc.
Current Parent Company: Endo International
Penalty: $464,900,000
Year: 2024
Date: February 29, 2024
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: opioid crisis litigation
Mega-Scandal: Opioid Crisis
Violation Description: Endo Health Solutions Inc., while in bankruptcy, agreed to resolve criminal and civil investigations related to the company's sales and marketing of the opioid drug Opana ER with INTAC. The agreement resolve all of the government's monetary claims arising from the criminal and civil settlements, as well as additional tax and healthcare related claims. Under the bankruptcy agreement, the government will be paid up to $464.9 million over 10 years. The company agreed to plead guilty in federal court in the Eastern District of Michigan to a one-count misdemeanor information charging it with violating the Federal Food, Drug and Cosmetic Act (FDCA) by introducing misbranded drugs into interstate commerce.
Level of Government: federal
Action Type: agency action
Agency: Justice Department Civil Division
Civil or Criminal Case: civil and criminal
HQ Country of Current Parent: Ireland
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Archived Source: (click here)
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.